Delivery Technologies Laboratory

What Delivery Technologies Laboratory does

Delivery Technologies Laboratory is a private, for-profit company founded in 2008, headquartered in Envigado, Colombia, with a reported headcount of 11–50 employees. According to its short description, the company serves the pharmaceutical and cosmetic sectors, with a stated possible focus on vaccine and genetic delivery solutions — implying activity in formulation, encapsulation, or transport systems for biologically active payloads destined for human or animal use.

Operational visibility into the company is severely limited. The corporate website at deliverytechnologies.com.co currently displays only a loading/verification page, and no products, services, proprietary technologies, patents, certifications, partnerships, management team, funding history, customer accounts, or pricing data are documented in the available inputs. There is no disclosed revenue, no investor information, no social media footprint captured, and no regulatory or compliance credentials listed. The revenue model, go-to-market motion, customer segmentation, and underlying technical architecture are therefore all unverified from primary sources.

As a result, the company should be treated as a thinly documented LatAm-based private entity in the bio-delivery / specialty formulation space. The combination of a 17-year operating history (founded 2008, evaluated at time of data capture), a small employee base, and a non-functional public-facing web presence raises material due-diligence questions about current operating status, commercial traction, and capital structure. Any investment thesis would require primary-source confirmation of active operations, validated customer references, and audited financials before directional conclusions can be drawn.

Name

Delivery Technologies Laboratory

Website

https://deliverytechnologies.com.co

Company type

Private

Founded year

2008

Headcount range

11–50 employees

Short description

Delivery Technologies Laboratory is a Colombia-based private company (founded 2008, 11–50 employees) operating in pharmaceutical and cosmetic delivery solutions, with a stated possible focus on vaccine and genetic delivery systems. Operational and commercial details are undocumented in available data.

Ownership category

akta.pro rank

Product category

Pharmaceutical Drug Delivery Technology

NAICS

Medical Equipment and Supplies Manufacturing (33911), Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Vaccine Delivery & Administration Systems (needle-free, microneedle patches, intranasal/oral) (HLAAAEAF)

akta.pro secondary industries

mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes) (IMALAIAF)

Keywords

• Drug delivery systems
• Vaccine delivery
• Genetic delivery
• Cosmetic formulation
• Pharmaceutical delivery

Headquarters

HQ city

Envigado

HQ country

Colombia

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Core offering

Delivery Technologies Laboratory develops and delivers delivery-technology solutions for the pharmaceutical and cosmetic sectors, with specific focus areas in vaccine delivery and genetic delivery. The firm operates as a laboratory-based provider serving companies seeking specialised formulation and delivery capabilities for bioactives and genetic materials.

Differentiator

Problem solved

Functional benefit

Products and services

• Vaccine delivery solutions Laboratory-based delivery-technology offerings intended for vaccine applications, serving pharmaceutical-sector clients.
• Genetic delivery solutions Laboratory-based delivery-technology offerings intended for genetic-material delivery applications, serving pharmaceutical-sector clients.
• Cosmetic delivery solutions Delivery-technology offerings targeted at the cosmetic sector, supporting formulation and delivery of cosmetic actives.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Expansion highlights1 record

Broad incumbents

• Recipharm: Large CDMO with capabilities across multiple dosage forms including advanced delivery formats. Comparable as a development-services counterpart that pharma customers may consider instead of a specialist lab.
• BD (Becton, Dickinson and Company): Global medical device leader with a major pharmaceutical systems segment covering prefilled syringes, needle-free injectors, and injection delivery devices. Comparable as a broad incumbent supplying vaccine and biologic delivery hardware into the same pharma customer base.
• Catalent: Global CDMO with deep biologics delivery, fill-finish, and formulation capabilities. Comparable as a development-and-manufacturing partner serving pharma customers looking to outsource delivery technology work.
• West Pharmaceutical Services: Established manufacturer of primary packaging and delivery components for injectable drugs, including elastomer closures, syringes, and novel delivery platforms. Overlaps with Delivery Technologies Laboratory on containment and administration of vaccines and biologics.

Direct peers

• PharmaJet: Developer of needle-free injection systems used to deliver vaccines and biologics. A direct functional peer given Delivery Technologies Laboratory's vaccine delivery focus and similar mechanism-driven delivery approach.
• Vaxxas: Clinical-stage company developing high-density microarray patch (HD-MAP) technology for needle-free vaccine and therapeutic delivery. Closely comparable as a specialist in alternative vaccine administration routes.
• Kindeva Drug Delivery: Specialist CDMO focused on inhalation, transdermal, and injectable drug delivery. Highly comparable business model combining proprietary delivery technology with development services for pharma clients.
• NanoPass Technologies: Developer of microneedle-based intradermal delivery technology for vaccines and therapeutics. A focused specialist directly comparable to Delivery Technologies Laboratory's vaccine delivery positioning.
• LTS Lohmann Therapie-Systeme: Specialist in transdermal therapeutic systems and active ingredient delivery patches. Comparable as a focused delivery technology partner serving both pharmaceutical and cosmetic/consumer health markets.
• Micron Biomedical: Developer of dissolvable microneedle technology for vaccines and therapeutics delivery. Directly comparable technology category and target customer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/deliverytechno

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Delivery Technologies Laboratory